vs

Side-by-side financial comparison of FONAR CORP (FONR) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.

FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $16.9M, roughly 1.5× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 2.4%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-227.0K). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs -0.3%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

FONR vs FVCB — Head-to-Head

Bigger by revenue
FONR
FONR
1.5× larger
FONR
$25.5M
$16.9M
FVCB
Growing faster (revenue YoY)
FVCB
FVCB
+4375.1% gap
FVCB
4377.5%
2.4%
FONR
More free cash flow
FVCB
FVCB
$24.0M more FCF
FVCB
$23.8M
$-227.0K
FONR
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
-0.3%
FONR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FONR
FONR
FVCB
FVCB
Revenue
$25.5M
$16.9M
Net Profit
$2.1M
Gross Margin
Operating Margin
13.5%
43.7%
Net Margin
8.0%
Revenue YoY
2.4%
4377.5%
Net Profit YoY
4.7%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
FVCB
FVCB
Q4 25
$25.5M
$16.9M
Q3 25
$26.0M
$416.0K
Q2 25
$27.3M
$15.8M
Q1 25
$27.2M
$382.0K
Q4 24
$24.9M
$378.0K
Q3 24
$25.0M
$412.0K
Q2 24
$25.9M
$415.0K
Q1 24
$25.7M
$359.0K
Net Profit
FONR
FONR
FVCB
FVCB
Q4 25
$2.1M
Q3 25
$2.3M
$5.6M
Q2 25
$729.3K
$5.7M
Q1 25
$2.5M
$5.2M
Q4 24
$2.0M
Q3 24
$3.1M
$4.7M
Q2 24
$830.4K
$4.2M
Q1 24
$1.9M
$1.3M
Operating Margin
FONR
FONR
FVCB
FVCB
Q4 25
13.5%
43.7%
Q3 25
14.1%
Q2 25
5.3%
45.9%
Q1 25
15.2%
Q4 24
11.9%
Q3 24
21.0%
Q2 24
7.4%
Q1 24
16.8%
Net Margin
FONR
FONR
FVCB
FVCB
Q4 25
8.0%
Q3 25
8.7%
1341.1%
Q2 25
2.7%
36.0%
Q1 25
9.2%
1352.1%
Q4 24
7.9%
Q3 24
12.6%
1133.3%
Q2 24
3.2%
1001.2%
Q1 24
7.3%
373.3%
EPS (diluted)
FONR
FONR
FVCB
FVCB
Q4 25
$0.31
Q3 25
$0.31
Q2 25
$0.31
Q1 25
$0.28
Q4 24
$0.27
Q3 24
$0.25
Q2 24
$0.23
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
FVCB
FVCB
Cash + ST InvestmentsLiquidity on hand
$121.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$176.9M
$253.6M
Total Assets
$217.2M
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
FVCB
FVCB
Q4 25
$121.0K
Q3 25
$122.0K
Q2 25
$56.5M
Q1 25
$123.0K
Q4 24
$121.0K
Q3 24
$136.0K
Q2 24
$56.5M
Q1 24
$134.0K
Total Debt
FONR
FONR
FVCB
FVCB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$66.9K
Q1 24
Stockholders' Equity
FONR
FONR
FVCB
FVCB
Q4 25
$176.9M
$253.6M
Q3 25
$174.9M
$249.8M
Q2 25
$172.6M
$243.2M
Q1 25
$171.9M
$242.3M
Q4 24
$169.8M
$235.4M
Q3 24
$168.7M
$230.8M
Q2 24
$166.0M
$226.5M
Q1 24
$165.8M
$220.7M
Total Assets
FONR
FONR
FVCB
FVCB
Q4 25
$217.2M
$2.3B
Q3 25
$218.4M
$2.3B
Q2 25
$216.9M
$2.2B
Q1 25
$214.9M
$2.2B
Q4 24
$208.0M
$2.2B
Q3 24
$212.3M
$2.3B
Q2 24
$214.2M
$2.3B
Q1 24
$209.6M
$2.2B
Debt / Equity
FONR
FONR
FVCB
FVCB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
FVCB
FVCB
Operating Cash FlowLast quarter
$171.0K
$23.9M
Free Cash FlowOCF − Capex
$-227.0K
$23.8M
FCF MarginFCF / Revenue
-0.9%
140.7%
Capex IntensityCapex / Revenue
1.6%
0.3%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M
$40.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
FVCB
FVCB
Q4 25
$171.0K
$23.9M
Q3 25
$1.7M
$7.6M
Q2 25
$4.2M
$3.3M
Q1 25
$3.1M
$5.4M
Q4 24
$2.2M
$18.2M
Q3 24
$1.7M
$4.7M
Q2 24
$4.6M
$1.6M
Q1 24
$2.8M
$7.2M
Free Cash Flow
FONR
FONR
FVCB
FVCB
Q4 25
$-227.0K
$23.8M
Q3 25
$-177.0K
$7.6M
Q2 25
$3.6M
$3.3M
Q1 25
$2.6M
$5.4M
Q4 24
$1.5M
$18.1M
Q3 24
$-148.0K
$4.6M
Q2 24
$4.2M
$1.5M
Q1 24
$2.6M
$7.1M
FCF Margin
FONR
FONR
FVCB
FVCB
Q4 25
-0.9%
140.7%
Q3 25
-0.7%
1818.0%
Q2 25
13.1%
20.8%
Q1 25
9.4%
1413.6%
Q4 24
6.0%
4786.0%
Q3 24
-0.6%
1121.8%
Q2 24
16.1%
361.2%
Q1 24
10.2%
1988.3%
Capex Intensity
FONR
FONR
FVCB
FVCB
Q4 25
1.6%
0.3%
Q3 25
7.2%
0.2%
Q2 25
2.4%
0.1%
Q1 25
2.2%
4.2%
Q4 24
3.0%
37.3%
Q3 24
7.2%
14.1%
Q2 24
1.6%
12.8%
Q1 24
0.7%
3.9%
Cash Conversion
FONR
FONR
FVCB
FVCB
Q4 25
0.08×
Q3 25
0.75×
1.36×
Q2 25
5.79×
0.58×
Q1 25
1.26×
1.05×
Q4 24
1.14×
Q3 24
0.53×
1.00×
Q2 24
5.54×
0.37×
Q1 24
1.50×
5.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

FVCB
FVCB

Segment breakdown not available.

Related Comparisons